Pacific Biosciences of California, Inc. Stock
Equities
PACB
US69404D1081
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.02 USD | -7.76% | +14.12% | -79.41% |
Financials (USD)
Sales 2024 * | 186M | Sales 2025 * | 247M | Capitalization | 550M |
---|---|---|---|---|---|
Net income 2024 * | -248M | Net income 2025 * | -201M | EV / Sales 2024 * | 5.28 x |
Net Debt 2024 * | 434M | Net Debt 2025 * | 469M | EV / Sales 2025 * | 4.13 x |
P/E ratio 2024 * |
-2.18
x | P/E ratio 2025 * |
-2.82
x | Employees | 796 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.13% |
Latest transcript on Pacific Biosciences of California, Inc.
1 day | -7.76% | ||
1 week | +14.12% | ||
Current month | +22.42% | ||
1 month | +38.36% | ||
3 months | -64.81% | ||
6 months | -75.95% | ||
Current year | -79.41% |
Managers | Title | Age | Since |
---|---|---|---|
Stephen Turner
FOU | Founder | 56 | 00-07-13 |
Christian Henry
CEO | Chief Executive Officer | 56 | 18-07-31 |
Susan Kim
DFI | Director of Finance/CFO | 48 | 20-09-27 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Milligan
CHM | Chairman | 63 | 13-07-17 |
Marshall Mohr
BRD | Director/Board Member | 67 | 12-01-17 |
Christian Henry
CEO | Chief Executive Officer | 56 | 18-07-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.87% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 2.02 | -7.76% | 8,137,826 |
24-05-16 | 2.19 | +2.10% | 12,992,736 |
24-05-15 | 2.145 | -3.81% | 15,793,797 |
24-05-14 | 2.23 | +15.54% | 26,365,041 |
24-05-13 | 1.93 | +9.04% | 17,024,189 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-79.41% | 550M | |
+12.15% | 227B | |
+14.90% | 197B | |
+18.22% | 141B | |
+29.15% | 110B | |
+0.53% | 64.15B | |
+16.92% | 53.72B | |
+6.33% | 51.75B | |
+10.93% | 45.2B | |
+5.87% | 37.37B |
- Stock Market
- Equities
- PACB Stock